CEB-01

DRUG2 trials

Sponsors

CEBIOTEX

Conditions

Locally Resectable Paediatric TumoursPancreatic Carcinoma

Phase 2

CEB-01 in Locally Resectable Pancreatic Cancer

RecruitingNCT06538857

CEBIOTEXPancreatic Carcinoma

Start: 2024-08-20End: 2028-09-30Target: 39Updated: 2025-05-23

CEB-01 in Paediatrics With Locally Resectable Abdominal Tumours

RecruitingNCT06986811

CEBIOTEXLocally Resectable Paediatric Tumours

Start: 2025-05-06End: 2029-05-31Target: 60Updated: 2025-05-31